Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/04/2003US6641833 Extended release of paclitaxel by intraperitoneal administration
11/04/2003US6641824 Skin treatment using a new retinoid
11/04/2003US6641810 Methods of using geldanamycin and FK506 to treat peripheral nerve damage
11/04/2003US6641806 Inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, nonbovine proteoglycan such as
11/04/2003US6641801 Common cold is caused by a virus. Antiviral compounds that kill viruses would then be most likely to serve as a remedy for the common cold. Invention seeks to offer a unique use of an antiviral agent, ethanol (with or without additional herbs
11/04/2003US6641800 Administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers
11/04/2003US6641798 Tumor-targeted optical contrast agents
11/04/2003US6641611 A coating for an intravascular implant that prevents hyperproliferative vascular disease, includes repamyicin as first agent which acts on calcium independent cellular pathway and second agent is cyclosporin A
11/04/2003US6641571 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
11/04/2003US6641063 Milling process for the production of finely milled medicinal substances
11/04/2003CA2296109C Improved process for antiparasitic agent
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2272483C Pyrazoles
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2257322C Thiazole derivatives
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
11/04/2003CA2175470C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
11/04/2003CA2096515C Benzo[b]thiophen-3-yl-piperazines, a process for their preparation and their use as medicaments
11/04/2003CA2094773C 2,4-dioxoimidazolidine derivatives
11/04/2003CA2091001C Baccatine iii derivatives
11/04/2003CA2078517C Process for the preparation of omeprazole
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089667A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/30/2003WO2003089642A1 Oligonucleotide compositions and their use for the modulation of immune responses
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089615A2 Antiviral inhibitions of capsid proteins
10/30/2003WO2003089601A2 3-deoxyglucosone and skin
10/30/2003WO2003089597A2 Use of cox-2 inhibitors to prevent recurrences of herpesvirus infections
10/30/2003WO2003089596A2 Novel prostate tumor-specific promoter
10/30/2003WO2003089593A2 Adjuvant enhanced immunotherapy
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089577A2 Antihelminthic anthraquinones and method of use thereof
10/30/2003WO2003089576A2 Anticancer anthraquinones and method of use thereof
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089568A2 Method of inhibiting restenosis
10/30/2003WO2003089476A1 Cross-linked hyaluronate compounds
10/30/2003WO2003089449A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/30/2003WO2003089440A1 Polymorph of ascomycin derivative
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089429A1 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
10/30/2003WO2003089428A1 Tricyclic thrombin receptor antagonists
10/30/2003WO2003089427A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003WO2003089426A1 Medicine for prevention and/or therapy of disseminated intravascular coagulation syndrome
10/30/2003WO2003089425A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-$g(a), $g(a)-dimethyl-benzeneacetic
10/30/2003WO2003089423A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents
10/30/2003WO2003089421A1 Antiviral lactone-ureas
10/30/2003WO2003089419A1 New 2-substituted -1,3-thiazole compounds
10/30/2003WO2003089418A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003WO2003089415A1 Amonafide salts
10/30/2003WO2003089414A1 Amlodipine nicotinate and process for the preparation thereof
10/30/2003WO2003089413A1 Pharmacia corporation
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/30/2003WO2003089409A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089024A1 Stents containing pyridine-substituted pyrazolopyridine derivatives
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003089007A1 Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
10/30/2003WO2003089006A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003WO2003089005A1 Drugs for treating vascular diseases
10/30/2003WO2003089004A1 Preventives for hiv infection
10/30/2003WO2003089001A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
10/30/2003WO2003088996A2 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088986A1 Curcumin for the prevention and/or treatment of tissue damage
10/30/2003WO2003088984A1 Compositions and methods for augmenting kidney function
10/30/2003WO2003088980A1 Method and composition for preventing pain in sickle cell patients
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
10/30/2003WO2003088978A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088976A1 Method for treating and preventing hyperparathyroidism
10/30/2003WO2003088975A1 Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation
10/30/2003WO2003088974A1 Pharmaceutical composition
10/30/2003WO2003088973A1 Combination of brimonidine and timolol for topical ophthalmic use
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088971A1 Combination therapy for the treatment of cancer
10/30/2003WO2003088970A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003WO2003088969A1 Anhydrovinblastine for the treatment of cancer
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088966A1 The use of hydroxypyridone-derivatives in wound healing
10/30/2003WO2003088965A1 Use of materials having zinc ionophoric behavior
10/30/2003WO2003088964A1 Use of cyclopamine in the treatment of psoriasis and other skin disorders
10/30/2003WO2003088962A1 Combination therapy using a ppar alpha/gamma agonist
10/30/2003WO2003088961A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/30/2003WO2003088960A1 Anti-tumour agents
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003088958A2 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson’s disease
10/30/2003WO2003088957A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
10/30/2003WO2003088956A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003WO2003088955A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
10/30/2003WO2003088954A1 Combination therapy for the treatment of cancer
10/30/2003WO2003088953A2 Multiphasic diet
10/30/2003WO2003088952A1 Sustained release of guaifenesin combination drugs
10/30/2003WO2003088948A2 Microemulsions for selective molecular separation
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088944A1 Dry powder inhalant composition
10/30/2003WO2003088943A1 Dry powder compositions
1 ... 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 ... 7860